MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

MiMedx Group Company Profile (NASDAQ:MDXG)

Consensus Ratings for MiMedx Group (NASDAQ:MDXG) (?)
Ratings Breakdown: 1 Hold Rating(s), 4 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.17 (39.93% upside)

Analysts' Ratings History for MiMedx Group (NASDAQ:MDXG)
Show:
DateFirmActionRatingPrice TargetActions
6/29/2016Brean CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016First AnalysisDowngradeOverweight -> Equal Weight$14.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/19/2016Lake Street CapitalLower Price TargetBuy$15.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/11/2016Needham & Company LLCLower Price TargetStrong-Buy$13.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2016Canaccord GenuityReiterated RatingBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015Northland SecuritiesUpgradeMarket Perform -> Outperform$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for MiMedx Group (NASDAQ:MDXG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
4/26/2016Q116$0.05$0.04$54.05 million$53.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2016Q415$0.06$0.12$51.84 million$51.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015Q315$0.06$0.06$48.61 million$49.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q215$0.04$0.05$45.03 million$45.68 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2015Q1$0.03$0.04ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q414$0.03$0.03$38.15 million$39.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314$0.02$0.03$33.50 million$33.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2014Q114($0.02)($0.01)$19.09 million$19.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2014Q4($0.01)($0.04)$18.31 million$18.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2013Q2 2013($0.01)($0.01)$12.94 million$13.52 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2013Q1 2013($0.02)($0.02)$11.34 million$11.56 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for MiMedx Group (NASDAQ:MDXG)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.03$0.05$0.04
Q2 20163$0.02$0.06$0.05
Q3 20163$0.05$0.08$0.07
Q4 20163$0.08$0.13$0.10
Q1 20172$0.06$0.10$0.08
Q2 20171$0.12$0.12$0.12
Q3 20171$0.13$0.13$0.13
Q4 20171$0.12$0.12$0.12
(Data provided by Zacks Investment Research)
Dividend History for MiMedx Group (NASDAQ:MDXG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for MiMedx Group (NASDAQ:MDXG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/16/2016William Charles TaylorCOOSell24,333$7.52$182,984.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Parker H PetitCEOBuy20,000$6.99$139,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2016Parker H PetitCEOBuy30,000$6.82$204,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2016Parker H PetitCEOBuy40,000$6.75$270,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2016Parker H PetitCEOBuy50,000$6.74$337,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2015Charles Robert EvansDirectorBuy10,000$7.84$78,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015Parker H PetitCEOBuy131,925$7.58$999,991.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2015Alexandra O. HadenGeneral CounselBuy4,150$7.92$32,868.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2015Larry W PapasanDirectorSell5,958$10.09$60,116.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2015William Charles TaylorCOOSell150,000$10.01$1,501,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014William Charles TaylorCOOSell150,000$10.01$1,501,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014William Charles TaylorCOOSell150,000$7.50$1,125,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/17/2014Parker PetitCEOSell150,000$8.28$1,242,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2013William Charles TaylorCOOSell9,800$6.15$60,270.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2013William Charles TaylorCOOSell183,765$6.21$1,141,180.65View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2013Steve GorlinDirectorSell30,000$6.46$193,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for MiMedx Group (NASDAQ:MDXG)
DateHeadline
06/29/16 05:00 PMIt Seems MiMedx Group Inc Will Go Up. Have Another Big Increase - Press Telegraph
06/29/16 07:57 AMEquity Research and Technical Review on MiMedx Group, Inc (NASDAQ:MDXG) - Press Telegraph
06/29/16 07:57 AMMiMedx Group Inc (MDXG) Jumps 8.16% on June 28 - Equities.com
06/28/16 09:57 AMMimedx Group Incorporated (NASDAQ:MDXG) Shorted Shares Decreased By 0.77% - Press Telegraph
06/27/16 08:17 AMMiMedx Group, Inc. breached its 50 day moving average in a Bearish Manner : MDXG-US : June 27, 2016 -
06/25/16 08:53 AMMiMedx Group, Inc (NASDAQ:MDXG): Growth Forecast - RealistInvestor.com
06/22/16 05:01 PMMiMedx Reaches Settlement With Medline Industries And Liventa Bioscience For Certain Claims
06/22/16 09:52 AMMiMedx Group (MDXG), Medline Industries, Liventa Bioscience Enter Settlement Agreement - StreetInsider.com
06/21/16 04:48 PMMiMedx Group (MDXG), Medline Industries, Liventa Bioscience Enter Settlement Agreement
06/21/16 08:03 AMResearch Report Initiated on Select Healthcare Equities -
06/20/16 05:52 AMMiMedx Group, Inc (MDXG) Analyst Price Targets For The Coming Week - Fiscal Standard
06/18/16 09:25 AMAnalyst’s Ratings on: MiMedx Group (NASDAQ:MDXG)
06/17/16 11:09 AMMiMedx Group, Inc. – Value Analysis (NASDAQ:MDXG) : June 17, 2016 -
06/15/16 07:27 AMMiMedx Group, Inc. breached its 50 day moving average in a Bearish Manner : MDXG-US : June 15, 2016 -
06/08/16 05:28 PMMIMEDX GROUP INC. (NASDAQ:MDXG) Financial Condition Compared to S&P 500 - CML News
06/06/16 08:50 AMTwo Buzzers to Observe: Cigna Corporation (NYSE:CI) , MiMedx Group, Inc (NASDAQ:MDXG) - Street Updates
06/04/16 05:06 PMBuy Rating Stocks: MiMedx Group, Inc. (NASDAQ:MDXG), Advanced Semiconductor Engineering Inc. (NYSE:ASX) - Beacon Chronicle
06/02/16 05:28 PMRecent Update on Price Movements: MiMedx Group, Inc (NASDAQ:MDXG) , Rexahn Pharmaceuticals, Inc. (NYSEMKT ... - Street Updates - Recent Update on Price Movements: MiMedx Group, Inc (NASDAQ:MDXG) , Rexahn Pharmaceuticals, Inc. (NYSEMKT ...Street UpdatesMiMedx Group, Inc. (MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports ...
06/02/16 08:01 AMPrice Target by Brokers: Verint Systems Inc. (NASDAQ:VRNT), MiMedx Group, Inc. (NASDAQ:MDXG) - Beacon Chronicle - Price Target by Brokers: Verint Systems Inc. (NASDAQ:VRNT), MiMedx Group, Inc. (NASDAQ:MDXG)Beacon ChronicleLast Trade: The Company closed its last session at $33.44 with the gain of 1.36%. The market capitalization of the company is $2.07 Billion, with the average Volume of 707.30K. The stock currently has its 52-Week High range of $66.17 and 52-week low ...and more »
06/02/16 08:01 AMMiMedx Group, Inc (NASDAQ:MDXG) Stock Update & Estimates - Stock Tick Tock - MiMedx Group, Inc (NASDAQ:MDXG) Stock Update & EstimatesStock Tick TockThe consensus on Wall Street is expecting MiMedx Group, Inc (NASDAQ:MDXG) to post earnings of $0.04 per share when the firm next reports it's fiscal quarterly results. According to the latest information available the report will likely be issued ...
06/01/16 04:43 PMIndependent Clinical Case Series Demonstrates MiMedx dHACM, Along With Split Thickness Skin Grafts, Is Effective In Limb Salvage - [PR Newswire] - MARIETTA, Ga., June 1, 2016 /PRNewswire/ -- MiMedx Group, Inc. (MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today that the most recent peer-reviewed independent clinical case series of MiMedx EpiFix® allografts has been published. The paper, "Bone and Tendon Coverage via Dehydrated Human Amniotic/Chorionic Membrane and Split-Thickness Skin Grafting," was electronically published in the Journal of Reconstructive Microsurgery.
05/31/16 05:21 PMMiMedx Group, Inc (NASDAQ:MDXG) Set To Release Quarterly Earnings - Investor Newswire - MiMedx Group, Inc (NASDAQ:MDXG) Set To Release Quarterly EarningsInvestor NewswireAccording to a group of market experts surveyed by Zacks Research, MiMedx Group, Inc (NASDAQ:MDXG) is projected to report earnings of $0.09 for its recent quarter. The company plans to release its quarterly report on or around 2016-08-04. It should be ...and more »
05/31/16 09:14 AMTarget Check and Stock Performance Recap MiMedx Group, Inc (NASDAQ:MDXG) - HNN - Target Check and Stock Performance Recap MiMedx Group, Inc (NASDAQ:MDXG)HNNTracking stock performance from various views may help with share evaluation. Some investors might be more focused on short-term share action while others may prefer to view long-term performance. In recent session activity, MiMedx Group, Inc ...and more »
05/31/16 09:14 AMStock Review and Earnings Check on MiMedx Group, Inc (NASDAQ:MDXG) - HNN - Stock Review and Earnings Check on MiMedx Group, Inc (NASDAQ:MDXG)HNNCompany earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting MiMedx Group, Inc (NASDAQ:MDXG) to report quarterly EPS of $0.04. The company's next earnings report is expected to be published on or ...and more »
05/26/16 01:00 PMMiMedx To Present At The Jefferies 2016 Global Healthcare Conference - [PR Newswire] - MARIETTA, Ga., May 26, 2016 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic membrane and other birth tissues, human skin and bone, ...
05/26/16 12:33 AMInsiders Are Gradually Buying MiMedx Group, Inc. (NASDAQ:MDXG) - Wall Street Hints and News - Insiders Are Gradually Buying MiMedx Group, Inc. (NASDAQ:MDXG)Wall Street Hints and NewsAccording to the latest SEC filings, insiders at MiMedx Group, Inc. (NASDAQ:MDXG) have increased their position in the stock by 1.58% over the past 6 months. Insiders now own 5.40% of total outstanding shares. There are both legal and illegal types of ...and more »
05/25/16 06:57 PMStock Rating Review for MiMedx Group, Inc (NASDAQ:MDXG) - Wall Street Hints and News - Stock Rating Review for MiMedx Group, Inc (NASDAQ:MDXG)Wall Street Hints and NewsInvestors may choose to follow the views of professional Wall Street analysts that regularly track the company. Covering equity analysts presently have a consensus stock rating of 1.33 on shares of MiMedx Group, Inc (NASDAQ:MDXG). Covering analysts ...and more »
05/25/16 03:12 PMMIMEDX GROUP, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits -
05/24/16 07:15 PMMiMedx Group Inc (MDXG) Jumps 5.12% on May 24 - Equities.com - MiMedx Group Inc (MDXG) Jumps 5.12% on May 24Equities.comMiMedx Group Inc (MDXG) was among the biggest gainers on the Russell 2000 for Tuesday May 24 as the stock popped 5.12% to $7.59, representing a gain of $0.37 per share. Some 1.67 million shares traded hands on 9,230 trades, compared with an ...and more »
05/24/16 12:14 AMEarnings Review and Stock Rundown for MiMedx Group, Inc (NASDAQ:MDXG) - Wall Street Hints and News - Earnings Review and Stock Rundown for MiMedx Group, Inc (NASDAQ:MDXG)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting MiMedx Group, Inc (NASDAQ:MDXG) to post ...and more »
05/24/16 12:14 AMStock Paining Investors: MiMedx Group, Inc. (NASDAQ:MDXG) - Wall Street Hints and News - Stock Paining Investors: MiMedx Group, Inc. (NASDAQ:MDXG)Wall Street Hints and NewsMiMedx Group, Inc. (NASDAQ:MDXG) shares have underperformed for investors this year as the stock has dropped -31.74% for the year. Shareholders are shaking their heads and questioning their investment and pondering what their next move will be.and more »
05/23/16 12:20 PMTarget Check and Stock Performance Recap MiMedx Group, Inc (NASDAQ:MDXG) - Wall Street Hints and News - Target Check and Stock Performance Recap MiMedx Group, Inc (NASDAQ:MDXG)Wall Street Hints and NewsTracking stock performance from various views may help with share evaluation. Some investors might be more focused on short-term share action while others may prefer to view long-term performance. In recent session activity, MiMedx Group, Inc ...and more »
05/23/16 08:30 AMMiMedx to Attend the 13th Annual Craig-Hallum Institutional Investor Conference - [PR Newswire] - MARIETTA, Ga., May 23, 2016 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic membrane and other birth tissues, human skin and bone, ...
05/22/16 06:29 PMNext Weeks Broker Price Targets For MiMedx Group, Inc (MDXG) - Share Trading News - Next Weeks Broker Price Targets For MiMedx Group, Inc (MDXG)Share Trading NewsMiMedx Group, Inc has a 50 day moving average of 7.78 and a 200 day moving average of 8.25. The stock's market capitalization is 767.93M, it has a 52-week low of 6.64 and a 52-week high of 13.20. The share price of the company (MDXG) was up +2.19%, ...and more »
05/20/16 03:10 PMMIMEDX GROUP, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of -
05/20/16 12:18 AMBuy Calls Count For MiMedx Group, Inc (NASDAQ:MDXG) At 0 - Investor Newswire - Buy Calls Count For MiMedx Group, Inc (NASDAQ:MDXG) At 0Investor NewswireMiMedx Group, Inc (NASDAQ:MDXG) has a total of 5 Strong Buy recommendations and 0 Strong Sell calls as of 2016-05-18. One month ago, the count of strong buy ratings were 5 and strong sell ratings were 0. The mean analyst score was 1. A month earlier ...and more »
05/19/16 06:41 PMETF’s with exposure to MiMedx Group, Inc. : May 19, 2016 -
05/19/16 12:04 PMMIMEDX GROUP, INC. Financials -
05/19/16 12:14 AMMiMedx Group (MDXG) Affirms Q2 Guidance - StreetInsider.com - MiMedx Group (MDXG) Affirms Q2 GuidanceStreetInsider.comMiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, ...MiMedx Group, Inc (MDXG) Updated Broker RatingsRisers & FallersParker Petit Purchased 30000 Shares of MiMedx Group Inc (NASDAQ:MDXG)Wall Street Hints and NewsMiMedx Group, Inc (NASDAQ:MDXG) Hovering Around $6.98Equities FocusSonoran Weekly Reviewall 7 news articles »
05/18/16 07:03 PMUpbeat Stocks in Focus- Baxter International (NYSE:BAX), MiMedx Group (NASDAQ:MDXG), Talen Energy (NYSE:TLN) - Seneca Globe - Schaeffers ResearchUpbeat Stocks in Focus- Baxter International (NYSE:BAX), MiMedx Group (NASDAQ:MDXG), Talen Energy (NYSE:TLN)Seneca GlobeBaxter International Inc. (NYSE:BAX) was among the mix trends movers as shares Dropped -1.91% to $44.60. Baxter announces final exchange ratio of 1.1591 for Baxalta (BXLT) exchange offer (BAX). For each share of Baxter common stock that is validly ...Active Movers in Hot Line: AstraZeneca (NYSE:AZN), Baxter International (NYSE:BAX), Osiris Therapeutics (NASDAQ ...Street Wise Report (press release) (blog)all 34 news articles »
05/17/16 02:14 PMMiMedx Group, Inc. :MDXG-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/17/16 12:32 PMMiMedx Provides Reminder of May 18th Annual Shareholders Meeting - [at noodls] - MARIETTA, Ga., May 17, 2016 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market ...
05/17/16 07:42 AMMiMedx Files Lawsuit Against Osiris For False And Misleading Representations - [at noodls] - MARIETTA, Ga., May 17, 2016 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market ...
05/17/16 07:33 AM8:33 am MiMedx Group files lawsuit under the Lanham Act against Osiris Therapeutics (OSIR), citing 'false & misleading' statements and seeking injunctive relief & damages -
05/16/16 11:53 PMEarnings Estimates Highlight: MiMedx Group Inc (NASDAQ:MDXG) - News Oracle - News OracleEarnings Estimates Highlight: MiMedx Group Inc (NASDAQ:MDXG)News OracleLast Trade: The Company rose 1.05% and finished at $6.74. The daily volume was measured at 1.19 million shares. The 52-week high of the share price is $13.20 and the 52-week low is $6.64. The company has a market cap of $746.11 million. The stock ...MiMedx Group, Inc. (NASDAQ:MDXG) Near to Lift Curtain on 42537 EarningsStreet Registerall 183 news articles »
05/16/16 06:45 PMMiMedx Group, Inc. (NASDAQ:MDXG) Near to Lift Curtain on 42537 Earnings - Street Register - Street RegisterMiMedx Group, Inc. (NASDAQ:MDXG) Near to Lift Curtain on 42537 EarningsStreet RegisterMiMedx Group, Inc. (MDXG) added 1.05% to reach at the floor price of $6.74 as the company is set to share its next quarterly earnings on July 26, 2016. MDXG stock trades between $6.64 and $7.09 before the earnings release. Let's take a closer look at ...Earnings Estimates Highlight: MiMedx Group Inc (NASDAQ:MDXG)News Oracleall 187 news articles »
05/16/16 11:12 AMMiMedx to Present at the UBS 2016 Global Healthcare Conference - [at noodls] - MARIETTA, Ga., May 16, 2016 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic membrane and other birth tissues, human skin and bone, ...
05/14/16 06:30 PMNoteworthy Analysts Suggestions: MiMedx Group, Inc (NASDAQ:MDXG) , Radius Health, Inc. (NASDAQ:RDUS) - Street Updates - Noteworthy Analysts Suggestions: MiMedx Group, Inc (NASDAQ:MDXG) , Radius Health, Inc. (NASDAQ:RDUS)Street UpdatesOn 5/13/2016, shares of MiMedx Group, Inc (NASDAQ:MDXG) rose +1.05% in trading session and finally closed at $6.74. The company most recent volume stood at 1.2 million shares as compared to average volume of 903.14 thousand shares. Over the one ...and more »
05/13/16 07:26 PMMDXG: Insiders vs. Shorts - In the case of MiMedx Group Inc (MDXG), the total short interest at the 03/31/2016 settlement date was 19,627,940 shares, which compares to the average daily trading volume of just 989,574 shares, for a "days to cover" ratio of 19.83. When short sellers ...
05/12/16 07:59 PMMiMedx Group Becomes Oversold (MDXG) - A stock is considered to be oversold if the RSI reading falls below 30. In trading on Wednesday, shares of MiMedx Group Inc (MDXG) entered into oversold territory, hitting an RSI reading of 29.6, after changing hands as low as $6.73 per share. By ...
About MiMedx Group

MiMedx Group logoMiMedx Group, Inc. (MiMedx) is an integrated developer, manufacturer and marketer of regenerative biomaterial products and bioimplants processed from human amniotic membrane. The Company's biomaterial platform technologies include AmnioFix and EpiFix, its tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through its donor program, mothers delivering full-term Cesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. MiMedx processes the human amniotic membrane utilizing its Purion Process to produce an implant, which is referred as an allograft. MiMedx is the supplier of amniotic tissue, having supplied over 350,000 allografts for application in the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental sectors of healthcare. Its CollaFix technology combines a means of creating fibers from soluble collagen and a cross-linking process.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MDXG
  • CUSIP:
Key Metrics:
  • Previous Close: $7.98
  • 50 Day Moving Average: $7.56
  • 200 Day Moving Average: $8.15
  • P/E Ratio: 34.55
  • P/E Growth: 1.71
  • Market Cap: $874.19M
  • Current Quarter EPS Consensus Estimate: $0.31 EPS
Additional Links:
MiMedx Group (NASDAQ:MDXG) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha